COVID-19 Records

Gates Package — page 1356

of 1375 pages

← p.1355 p.1357 → · this page in the original PDF · package

© BLOCK TRANSMISSION Reducing transmission Reducing infection Transmission blockers applied How do we protect the nose and upper to the nose and upper airways airways from pathogens, so they are unable to infect and spread? Aeoues in 3 virus € alrways " neutralize the For'example: virus on entry + Innate immune activators New platforms for potent, durable, and * mRNA low-cost approaches that can be applied a encoded at scale to prevent pathogen 4=K biologics transmission + RNAI iM I + Low-cost durable , woe , antibodies Blocking transmission of respiratory or enteric pathogens PARTNERS: @ LUMEN & eleven INCENTIVES: Regulatory measures/endpoints for approval of BIOSCIENCE THERAPEUTICS @ EMORY transmission-reducing interventions, payment codes/infrastructure for Tether I Yale scHOOL OF MEDICINE Unitas transmission reduction, price/ volume guarantees (to be developed) Therapeutics MEDICINE Gf Not for distribution 16

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/gates/1356

Records on this page

RecordDateTypePages
gates:exh:00635 attachment 1356